Programmed death ligand-1 (PD-L1) expression in meningioma; prognostic significance and its association with hypoxia and NFKB2 expression

Management of clinically aggressive meningiomas is a considerable challenge. PD-L1 induced immune suppression has increasingly gained attention in clinical management of cancer; however, to date, the clinical significance and regulatory mechanisms of PD-L1 in meningioma is not yet fully characterize...

Descripción completa

Detalles Bibliográficos
Autores principales: Karimi, Shirin, Mansouri, Sheila, Mamatjan, Yasin, Liu, Jeff, Nassiri, Farshad, Suppiah, Suganth, Singh, Olivia, Aldape, Kenneth, Zadeh, Gelareh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445252/
https://www.ncbi.nlm.nih.gov/pubmed/32839486
http://dx.doi.org/10.1038/s41598-020-70514-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445252/
https://www.ncbi.nlm.nih.gov/pubmed/32839486
http://dx.doi.org/10.1038/s41598-020-70514-z

Ejemplares similares